Solid pseudopapillary tumor of the pancreas and concomitant urogenital malformations in a young woman by Zhi-Wei Guan et al.
Guan et al. Diagnostic Pathology 2013, 8:35
http://www.diagnosticpathology.org/content/8/1/35CASE REPORT Open AccessSolid pseudopapillary tumor of the pancreas and
concomitant urogenital malformations in a young
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Zhi-Wei Guan1, Lu Sun2, Yan-Qiu Wang3 and Bai-Xuan Xu1*Abstract
Solid pseudopapillary tumor (SPT) of the pancreas is a rare pancreatic tumor with low malignant potential. It occurs
characteristically more often in young women. SPT associated with extra- and pancreatic anomalies are occasionally
reported. Here we report a case of pancreatic SPT with concomitant urogenital malformations including solitary
kidney and uterus didelphys in a 25-year-old woman. The patient underwent central pancreatectomy, and SPT was
confirmed with pathological results. Recurrence or metastasis was not found after 14 months of follow-up.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/4264758678755142
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Solid pseudopapillary tumor (SPT) of the pancreas is
rare, accounting for 0.13-2.7% of all pancreatic tumors
[1]. It is unique, has low malignant potential and pre-
dominantly affects young women [1,2]. Radiological and
pathological studies have revealed that the tumor is
quite different from other pancreatic tumors [3-7]. But
the cell origin of SPT and tumorigenesis are still enig-
matic. Occasionally, SPT has been reported to be associ-
ated with extra- and pancreatic anomalies [8-11]. Here
we present radiological, PET/CT and histological find-
ings of a case of pancreatic SPT with concomitant uro-
genital malformations.Case presentation
A 25-year-old unmarried woman with no remarkable
past or family history of neoplasms was admitted to our
hospital due to a tumor located at the pancreatic neck,
which was incidentally found by abdominal ultrasound
during a medical check up. Physical examination re-
vealed no abnormal findings. There were no abnormal-
ities in clinical laboratory tests such as serum amylase* Correspondence: xbx301@yahoo.com
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reproduction in any medium, provided the orlevel or tumor markers, including AFP, CA199, CEA,
CA125, and CA724. Precontrast abdominal CT showed
a round hypo-attenuation mass approximately 4.5 cm in
diameter with clear margin. After contrast administra-
tion, the tumor displayed peripheral enhancement,
corresponding to the solid part of the tumor. Hypo-
attenuation without enhancement was depicted in the
central zone corresponding to cystic degeneration.
Pancreatic duct of the upper stream did not dilate. No
parenchymal atrophy or vessel invasion was found.
Accordingly, SPT was the most probable diagnosis, and
nonfunctional PNET was considered as the differential
diagnosis. Meanwhile, the left kidney was not found
within the coverage of the abdominal CT scan. Later, the
patient received FDG PET/CT scan covering from the
skull base to the upper part of the thigh for further
evaluation of the pancreatic tumor. With regard to the
PET findings, the pancreatic tumor showed inhomogen-
eous FDG uptake (Figure 1) with a maximum standard-
ized uptake value (SUVmax) of 7.5 in the peripheral
zone of solid component. The left kidney was still not
found. Interestingly, PET image showed two foci of
slight FDG-accumulation at the uterine cavity (Figure 2B),
and uterus didelphys were suspected. After consulting
the clinical paper of the patient, we found that she had
regular menses. She received abdominal ultrasound,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 The tumor was located in the body of the pancreas with intense FDG uptake (A-B, solid red arrow). The tumor exhibited
hypoattenuation on pre-contrast CT (C), and was enhanced inhomogeneously after contrast administration (D). The FDG accumulation was
mainly located in the peripheral part of the tumor (B), corresponding to the solid part of the tumor with enhancement (D). Only the right kidney
was found (A-D, red arrow).
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this patient, PET/CT helped to diagnose the unex-
pected urogenital agesi, and to determine the stage of
the pancreatic tumor as being confined without metas-
tasis. After PET/CT scan, the patient underwent central
pancreatectomy. Gross surgical specimen showed that
the tumor was well encapsulated by a fibrous pseudo-A B
Figure 2 Two linear foci of FDG accumulation in the central part of th
Ultrasound scan showed two cavities (blue arrows) with muscular septumcapsule with solid and cystic components. Microscopi-
cally, the tumor was composed of sheets and nests of
uniform polygonal epithelioid cells with round or oval
nuclei and acidophilic cytoplasm divided by thin
fibrovascula stroma. Degenerative changes were seen in
some parts of the tumor. Invasion of the vascular space
or perineural invasion was not identified. The prolifera-C
e uterus were found in the PET/CT fusion image (B, blue arrow).
(red arrow) (C).
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atypia was mild. According to immunohistochemical
analysis, the tumor cells showed nuclear type of β-catenin
(++), CD10 (+), CD56 (+), Vimentin (+), and α1-antitrypsin
(+), but were negative for chromogranin A (CgA) or
Synaptophysin (Syn). These finding supported a final diag-
nosis of SPT of the pancreas (Figure 3). The patient had a
smooth recovery and was released 10 days after resection.
Recurrence or metastasis was not found after 14 months
of follow-up.
Discussion
SPT is rare and far less common than the other pancre-
atic tumors, including ductal adenocarcinoma, cystic
and neuroendocrine tumors. It is occasionally found be-
cause of the vague symptoms, like those of some
nonfunctional neuroendocrine tumors [12]. In our case,
the pancreatic tumor was an occasional finding during
physical check-up, and was typical in terms of demo-
graphic figure, radiological feature and pathological find-
ings. First, it occurred in a young woman, which
represented the typical population. Previous studies have
shown that SPT predominantly affects young women
from 20 to 40 years old [1]. Second, it exhibited the typ-
ical radiological features on CT, including regular shape,Figure 3 A low power view showing the cystic components (arrowhe
of uniform polygonal epithelioid cells with round or oval nuclei and acidop
Pseudopapillary structures were observed. Cell atypia was mild and mitosis
C). Immunohistochemistry showed that the tumor cells were positive for C
×400, D-F).well-defined margin and inhomogeneous appearance
corresponding to the solid and cystic texture [2,3,5,13].
Such radiological features are very different from those
of ductal adenocarnoma, as the latter is always infiltra-
tive with poorly defined margin and is invasive to the
surrounding tissues. Last, the pathologic examination,
light microscopy and immunohistological staining re-
sults of our case were typical. The tumor is character-
ized with fibroscapsule surrounding and varied protion
of solid and cystic components showing hemorrhagic
changes [1-3]. Under light microscope, the pseu-
dopapillary structures and degenerative changes, such as
necrosis, hemorrhage, cholesterol clefts and foamy mac-
rophages, are characteristic findings [2]. Besides, the
tumor cells are characteristically uniform with mild
atypia and rare mitosis, indicating its benign entities
[1,2]. It is relatively easy to differentiate SPT from ductal
adenocarcinoma based on these histological features, as
the latter is ofter more moderately or poorly differenti-
ated and is composed of haphazardly arranged glands
admixed with a dense desmoplastic stroma [14]. Cystic
neoplasms, such as mucinous or serous cystic neoplasm,
can also be easily differentiated from SPT, because they
lack communication with the pancreatic duct system and
have no mucinous or serous epithelium usually supportedads) of the tumor (H&E, magnification ×12.5, A). Sheets and nests
hilic cytoplasm divided by thin fibrovascula stroma were found.
was not found (H&E, magnification ×200, B; H&E, magnification ×400,
D56 (D), CD10 (E), and the nuclear type of β-catenin (F) (Magnification
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especially the well-differentiated ones, are the most im-
portant entities in the differential diagnosis of SPT, be-
cause they may display similar light microscopic features,
and neuroendocrine markers are variably expressed in
SPT [1,2]. Excep for the consistently negative results for
chromogranin A, expressions of other neuroendocrine
markers such as synaptophysin, neuron-specific enolase
and CD56 at various levels were demonstrated [1,2,17,18].
Recently, the nuclear type of β-catenin has been regarded
as an unique immunohistochemical feature of SPT as it
underlies the genetic mutation of catenin found in more
than 90% of SPT [6,7]. Abnormal nuclear labeling of
β-catenin strongly supports the diagnosis of SPT. SPT is
largely benign according to its pathological features, but
interestingly, it always shows hyper-metabolism of FDG
on PET [19-21], which mimics malignant tumor. The high
cellular density, rich mitochondria and the hypervascular
nature as shown in radiological findings have been
thought to contribute to the FDG accumulation [19]. In
rare cases, SPT metastasizes to liver or transplants on
peritomeum. In this patient, PET/CT staged the tumor to
be confined without metastasis or transplantation, and she
had safely undergone central pancreatectomy. Because of
the indolent entity, patients usually have very good prog-
nosis with less likelihood of recurrence and metastasis
after resection of SPT [1,2]. Different from SPT, ductal
adenocarcinoma always has very poor prognosis even after
complete resection, as metastasis and recurrence are
common.
In our case, the urogenital anomalies of solitary kidney
and uterus didelphys were incidental findings. In
premenopausal women, uteral endometrium always dis-
play physiologic FDG uptake, and can be easily recog-
nized with its characteristically linear shape and central
location in the uterus [22]. But different from other pa-
tients, the patient in this case had two separate linear
FDG accumulations at the central part of her uterus, in-
dicating two locations of endometrium. So uterus
didelphys was suspected when we read the PET/CT
image and was confirmed by ultrasound.
SPT has been reported to occur occasionally in pa-
tients with pancreatic anormalies such as pancreatic dor-
sal agenesis [9,11] and pancreatic divicum [10,23]. There
is another report of SPT in a young woman with
Mulvihill-Smith syndrome (MSS), a congenital mental
anomaly characterized by progeria-like aspect, multiple
pigmented nevi, mental retardation, microcephaly, low
stature and lack of facial subcutaneous fat [8]. But this is
the first case of SPT with concomitant urogenital anom-
alies. The findings are very interesting because both SPT
and urogenital anomaly are very rare diseases. When
they were found in one patient, we wondered whether
the concomitant occurrence was just a coincidence.Recently, β-catenin and Wnt signaling pathway has
been found to play an important role in SPT tumo-
rigenesis [7,24-26]. SPT almost consistently harbors
β-catenin gene (CTNNB1) mutations in exon 3 [27],
resulting in the activation of the Wnt-signaling pathway.
The CTNNB1 gene mutations inactivate one of the
glycogen synthase kinase-3β phosphorylation sites on
the β-catenin protein, and block the degradation of
β-catenin. The β-catenin protein binds to the T-
cell transcription factor (Tcf )/lymphoidenhancer-bind-
factor (Lef ), and is then translocated to the nucleus, as
indicated by nuclear expression of β-catenin [25,26,28].
In the nucleus, the β-catenin-Tcf/Lef complex activates
the transcription of several oncogenic genes, including
c-myc and cyclin D1. As a matter of fact, activation of
β-catenin in mice induces large pancreatic tumor re-
sembling human SPT, presenting in vivo evidence that
β-catenin/Wnt signaling pathway plays a critical role in
SPT tumorigenesis [29]. Renal agenesis (RA) is embryo-
logically associated with genital malformations because
Wolffian or mesonephric duct has inductive function
on the Müllerian duct during normal development
[30,31]. Patients with urogenital malformations always
harbor Wnt muations or abnormal catenin [32,33]. Be-
sides, urogenital malformations are induced in mice
model by variable interruptions of the β-Catenin/Wnt-
signaling pathway [34], but the exact molecular me-
chanisms are so complicated and far from complete
disclosure.
As mentioned above, β-catenin and the Wnt-signaling
pathway play important roles in both SPT tumorigenesis
and urogenital malformations. We wondered whether the
concurrent tumor of SPT and urogenital malformations in
this young woman were triggered by a primary insult,
which subsequently served to propagate aberrant urogeni-
tal development as well as SPT tumoregenesis, a process
in which β-Catenin/Wnt-signaling pathway played import-
ant roles. But similar cases have not been found in the lit-
erature. The underlying molecular genetic mechanism and
the relationship between SPT and the congenital anomal-
ies need to be further investigated.
In conclusion, SPT is rare and specific in demography,
radiology and pathology. It is benign and the prognosis
is good after resection. It occasionally occurs in patients
with extra- and pancreatic anomalies. The concurrent
SPT and congenital malformations might be associated
with the β-catenin/Wnt-signaling pathway. But the asso-
ciation needs to be confirmed.
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